View in EDS HTML Full Text PDF Full Text

Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer.

Saved in:
Bibliographic Details
Title: Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer.
Authors: Arnold T; Surgical Research Laboratories, Department of Surgery, Medical University of Vienna, Vienna, Austria., Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R
Source: European journal of clinical investigation [Eur J Clin Invest] 2013 Mar; Vol. 43 (3), pp. 286-91. Date of Electronic Publication: 2013 Jan 25.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362 (Electronic) Linking ISSN: 00142972 NLM ISO Abbreviation: Eur J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2362
DOI:10.1111/eci.12043